Literature DB >> 18231113

Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells.

Kinga G Blecharz1, Detlev Drenckhahn, Carola Y Förster.   

Abstract

Recent studies have shown the influence of glucocorticoids on the expression of the tight junction protein occludin in the brain capillary endothelial cell line cEND, contributing to improvement in endothelial barrier functions. In this study, we investigated glucocorticoid effects on the expression of the adherens junction proteins VE- (vascular-endothelial) cadherin, alpha-catenin and beta-catenin as well as that of ZO-1, the plaque protein shared by both adherens and tight junctions on stimulation with dexamethasone. We were able to show a positive influence of dexamethasone administration on VE-cadherin protein levels as well as a rearrangement of VE-cadherin protein to the cytoskeleton after dexamethasone treatment. Investigation of transcriptional activation of the VE-cadherin promoter by dexamethasone, however, did not point to direct glucocorticoid-mediated VE-cadherin gene induction but rather suggested indirect steroid effects leading to increased VE-cadherin protein synthesis. Dexamethasone was further shown to induce cellular differentiation into a cobblestone cellular morphology and reinforcement of adherens junctions concomitant with the increased anchorage of VE-cadherin to the actin cytoskeleton. We thus propose that glucocorticoid effects on VE-cadherin protein synthesis and organization are important for the formation of both adherens and tight junction, and for improved barrier properties in microvascular brain endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18231113     DOI: 10.1038/jcbfm.2008.2

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  30 in total

1.  Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).

Authors:  Jennifer L Kielczewski; Sergio Li Calzi; Lynn C Shaw; Jun Cai; Xiaoping Qi; Qing Ruan; Lin Wu; Li Liu; Ping Hu; Tailoi Chan-Ling; Robert N Mames; Sue Firth; Robert C Baxter; Patric Turowski; Julia V Busik; Michael E Boulton; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-21       Impact factor: 4.799

Review 2.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

3.  Plasticity of button-like junctions in the endothelium of airway lymphatics in development and inflammation.

Authors:  Li-Chin Yao; Peter Baluk; R Sathish Srinivasan; Guillermo Oliver; Donald M McDonald
Journal:  Am J Pathol       Date:  2012-04-23       Impact factor: 4.307

4.  Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.

Authors:  Carola Förster; Malgorzata Burek; Ignacio A Romero; Babette Weksler; Pierre-Olivier Couraud; Detlev Drenckhahn
Journal:  J Physiol       Date:  2008-02-07       Impact factor: 5.182

Review 5.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

6.  Transendothelial movement of adiponectin is restricted by glucocorticoids.

Authors:  Thanh Q Dang; Nanyoung Yoon; Helen Chasiotis; Emily C Dunford; Qilong Feng; Pingnian He; Michael C Riddell; Scott P Kelly; Gary Sweeney
Journal:  J Endocrinol       Date:  2017-08       Impact factor: 4.286

7.  Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke Model.

Authors:  Alejandro Espinosa; Gabriela Meneses; Anahí Chavarría; Raúl Mancilla; José Pedraza-Chaverri; Agnes Fleury; Brandon Bárcena; Ivan N Pérez-Osorio; Hugo Besedovsky; Antonio Arauz; Gladis Fragoso; Edda Sciutto
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 8.  Minireview: Steroid/nuclear receptor-regulated dynamics of occluding and anchoring junctions.

Authors:  Gary L Firestone; Bhumika J Kapadia
Journal:  Mol Endocrinol       Date:  2014-09-09

9.  Interleukin 6-Mediated Endothelial Barrier Disturbances Can Be Attenuated by Blockade of the IL6 Receptor Expressed in Brain Microvascular Endothelial Cells.

Authors:  Kinga G Blecharz-Lang; Josephin Wagner; Alexa Fries; Melina Nieminen-Kelhä; Jörg Rösner; Ulf C Schneider; Peter Vajkoczy
Journal:  Transl Stroke Res       Date:  2018-02-10       Impact factor: 6.829

Review 10.  Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets.

Authors:  Richard F Keep; Anuska V Andjelkovic; Jianming Xiang; Svetlana M Stamatovic; David A Antonetti; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-08       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.